After Missing Roku, Netflix: Why Investors React Now
When Netflix reportedly missed out on Roku, investors asked: what does this mean for the company’s future profits and...
Articles — Page 601
Marvell Technology Soared 247%: Upside in 3-Year Outlook
Marvell Technology has surged this year as AI data centers ramp up demand. This guide breaks down whether the rally c...
Bitcoin's Been Holding Steady: Is It a Buy at 60K Now?
Bitcoin fans have watched a calm stretch emerge around the $60,000 mark. This article breaks down what that steady vi...
Is SCHD Better Dividend Than VIG? A Practical Guide
Choosing between SCHD and VIG comes down to your goals: current income vs. steady growth. This guide breaks down how ...
SpaceX's First Earnings Report: Four Key Things to Watch
Investors are buzzing about SpaceX going public and what the first earnings report might reveal. Here are four core a...
Quantum Computing Stocks with Big Upside Outpacing SpaceX
As SpaceX captures headlines, a quieter but powerful growth wave is building in quantum computing. This guide highlig...
Marvell Technology Semtech: Which Stock Is Better in 2026
Two chipmakers with different playbooks face the 2026 market. This guide breaks down Marvell Technology and Semtech, ...
Polymarket Reportedly Used Fake Bets to Spark Growth
A Wall Street Journal probe alleges polymarket used staged bets to fuel viral growth, prompting questions about trans...
Consistency Spells 2026 RealTrends: Gary Mercer Sr.
Gary Mercer Sr. rises in the RealTrends 2026 Verified rankings through relentless consistency, delivering standout vo...
Fathom Agents Briefed Bath Amid Bed Bath & Beyond Deal Framework
Fathom Holdings unveils a plan to expand beyond a single-transaction model after agreeing to be acquired by Bed Bath ...
Will Really Hike Rates? Banks Probe 2026 Federal Path
Bank of America signals three quarter-point rate increases in 2026, rattling lenders and borrowers alike. Here’s what...
Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...